Customer reports of discoloration have prompted AuroMedics Pharma to pull more than 100,000 bottles of a prescription antibiotic used to treat bacterial conjunctivitis.
Customer reports of discoloration have prompted AuroMedics Pharma to pull more than 100,000 bottles of a prescription antibiotic used to treat bacterial conjunctivitis.
The CDC is seeking special emergency authorization from the FDA to allow US states to use a CDC-developed diagnostic test to detect the new coronavirus from China.
The CDC is seeking special emergency authorization from the FDA to allow US states to use a CDC-developed diagnostic test to detect the new coronavirus from China.
The Centers for Disease Control and Prevention have released new guidance for health care providers regarding the evaluation of patients with suspected novel coronavirus in response to the ongoing outbreak of novel coronavirus in Wuhan City,...
The Centers for Disease Control and Prevention have released new guidance for health care providers regarding the evaluation of patients with suspected novel coronavirus in response to the ongoing outbreak of novel coronavirus in Wuhan City,...
The first US case of novel coronavirus has been confirmed in Washington state. The patient had recently returned from Wuhan, China, the original site of the outbreak.
The first US case of novel coronavirus has been confirmed in Washington state. The patient had recently returned from Wuhan, China, the original site of the outbreak.
Between 2018 and 2019, use of JUUL vaping devices doubled among U.S. young people aged 18 to 20 and more than tripled among those aged 21 to 24, study findings show.
Between 2018 and 2019, use of JUUL vaping devices doubled among U.S. young people aged 18 to 20 and more than tripled among those aged 21 to 24, study findings show.
Drug companies are not making progress against the spread of antibiotic resistance at a scale and speed great enough to tackle the global health threat posed by superbugs, a key benchmark analysis found.
Drug companies are not making progress against the spread of antibiotic resistance at a scale and speed great enough to tackle the global health threat posed by superbugs, a key benchmark analysis found.
"Our blood pressure trajectories data indicate that women really are different from men when it comes to how we define the health of our blood vessels and how the blood vessels respond to exposures and stressors over the life course," said...
"Our blood pressure trajectories data indicate that women really are different from men when it comes to how we define the health of our blood vessels and how the blood vessels respond to exposures and stressors over the life course," said...
The predominance of A(H3N2) clade 3C.3a viruses during the latter part of the 2018-2019 influenza season was associated with a decrease in vaccine effectiveness, according to results of a new study.
The predominance of A(H3N2) clade 3C.3a viruses during the latter part of the 2018-2019 influenza season was associated with a decrease in vaccine effectiveness, according to results of a new study.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
Featuring Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Featuring Chris Fausel, PharmD, MHA, ...
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...